Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 225 of 1,261
  1. US 11505585

    FcRn antagonists and methods of use

    The Board of Regents of the University of Texas System · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  2. US 11505574

    Modulation of P53 for the treatment of cancer

    The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  3. US 11505564

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  4. US 11504426

    Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  5. US 11503999

    Hyperspectral imaging for detection of Alzheimer's disease

    Regents of the University of Minnesota · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  6. US 11505782

    Cell-based vehicles for potentiation of viral therapy

    Calidi Biotherapeutics, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  7. US 11505601

    Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum

    Nanjing Legend Biotech Co., Ltd · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  8. US 11505604

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  9. US 11505598

    Antibodies to botulinum neurotoxins

    The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  10. US 11505575

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  11. US 11505591

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  12. US 11505588

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  13. US 11504427

    Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy

    The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  14. US 11505551

    Methods for preparing substituted pyridinone-containing tricyclic compounds

    ARBUTUS BIOPHARMA CORPORATION · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  15. US 11505525

    Branched discrete PEG constructs

    Quanta BioDesign, Ltd. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  16. US 11504429

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  17. US 11505572

    Therapeutics for the treatment of glaucoma

    Regents of the University of Minnesota · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  18. US 11504394

    Targeted ionophore-based metal delivery

    The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  19. US 11504403

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  20. US 11504391

    Modified RNA agents with reduced off-target effect

    Alnylam Pharmaceuticals, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  21. US 11504390

    Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  22. US 11504346

    Redox-activated pro-chelators

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  23. US 11504364

    Inhibitors of fibroblast activation protein

    PRAXIS BIOTECH LLC · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  24. US 11505594

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.